This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The screening and brief intervention comprised two elements: screening using the Alcohol Use Disorders Identification Test (AUDIT); and treatment by a brief intervention in the general practice (GP) setting that involved medical staff talking to the patient about alcohol consumption. The base case screening scenario was that screening/treatment was assumed to occur at registration with a new GP. The comparator was do nothing (no intervention). All positive screens were assumed to be immediately offered and accept treatment with screening and brief intervention.
Location/setting

UK/Primary Care
Methods
Analytical approach:
The Sheffield Alcohol Policy Model (see Other Publications of Related Interest) was extended to incorporate the effect of reducing alcohol consumption through the screening and brief intervention. The model was evaluated from a NHS and Personal Social Services perspective over a 30-year period. The model assumed that the screening programme ran for 10 years and that there were no repeat screens.
Effectiveness data:
The primary measure of effectiveness was percentage reduction in alcohol consumption after the brief intervention. This measure was derived from a systematic review of the AUDIT screening survey and intervention (see Other Publications of Related Interest). Screening arrival profiles and sensitivity and specificity of screening were derived from both national and published data. The effect of the intervention was expected to rebound to baseline over a sevenyear period. The published model used published epidemiological evidence to translate alcohol consumption into the risk of 47 harmful health effects which were subsequently used to modify mortality and morbidity outcomes. Life tables were used to estimate the effect of the intervention on subgroups of the population based on sex, age and baseline drinking status.
Measure of benefit:
The summary measure of benefit was quality-adjusted life-years (QALYs). Future benefits were discounted at 3.5% annually.
Cost data:
The cost estimates for the intervention were staff time and material costs. The intervention was assumed to last five minutes in the base case at a cost of £0.55/minute assuming that a practice nurse carried out the intervention. The unit costs were derived from Personal and Social Service Research Unit (PSSRU) costs. Alternative assumptions about length of intervention and type of staff performing the intervention were tested in sensitivity analyses. Material costs for performing the screening and intervention were derived from a published economic evaluation of a brief intervention for alcohol consumption. The price year was 2007. Future costs were discounted at 3.5% annually. The impact of reduced morbidity prevalence for the 47 harmful health effects were included but as they were an integral part of the original model full details have not been presented in this publication.
Analysis of uncertainty:
The analysis of uncertainty was evaluated using one-way and scenario analyses where adjusted parameters included: duration of the intervention, who undertook the intervention, effectiveness of the intervention and length of the rebound period. Additional scenarios altered the type of intervention by changing the survey used and varying the intervention characteristics and whether the intervention was carried out at new registration or next consultation with a GP. A three-year rebound rate for the effectiveness of the intervention was tested in sensitivity analyses.
Results
Where screening/treatment by a nurse was assumed to occur at registration with a new GP it was dominant (less costly and more effective) compared with do nothing (no intervention). Costs of delivering screening and brief intervention over a 10-year period was estimated at £95 million but with potential 30-year savings of £215 million and QALY gains of 32,000. The authors felt that the assumptions in this base case (fully reported) represented the best attempt at representing the evidence base.
Alternative scenarios showed that if the intervention was assumed to have a duration of 24.9 minutes (matching the systematic review) it remained dominant when delivered by a nurse and achieved an incremental cost-effectiveness ratio (ICER) of £11,200/QALY if delivered by a GP. The most pessimistic scenario resulted in an ICER of £75,000.
Having established that the base case strategy was cost-effective under most plausible assumptions, alternative comparators were compared against the base case. These analyses suggested that screening at next consultation (rather than new registration) would be cost-effective compared to current practice (the base case) but its implementation would require substantial front-loaded resources.
